Skip to content

CMT Awareness Blog

CMTA Updates List of Neurotoxic Meds Potentially More Hazardous to CMT Patients

CMTA has updated its Neurotoxic Drug List following a comprehensive scientific review of medications known or suspected to affect peripheral nerves. The review found that, with two specific anticancer drugs, most medications pose no greater risk to people with CMT than to the general population, helping patients and clinicians make informed treatment decisions.

CMTA Kicks Off CMT Awareness Month 2022

CMTA kicks off CMT Awareness Month 2022 with a month-long series of educational and community-driven activities designed to increase understanding of CMT. The campaign highlights people living with CMT and encourages public participation through digital engagement and awareness efforts.